A cell and gene therapy CDMO needed to transfer manufacturing and analytical methods for eight unique products to a new site. We conducted risk assessments, developed transfer protocols, and created master batch records and SOPs across every program.
Impact for the client:
- Successful tech transfer for all eight products
- Regulatory alignment maintained throughout
- Downtime minimized and operational continuity preserved
